Novel flow cytometry-based assay for HIV-infected cells
Novel flow cytometry-based assay for HIV-infected cells
批准号:
8656014
负责人:
JOSEPH M MCCUNE
金额:
$22.06万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-01 至 2015-11-30
关键词:
Acquired Immunodeficiency SyndromeAgeBiological AssayBiological ModelsBloodCD4 Positive T LymphocytesCardiovascular DiseasesCell CountCell LineCellsCellular AssayDNADetectionDevelopmentDiseaseDisease ProgressionEffectivenessEpidemicEvaluationEventFlow CytometryFluorescent in Situ HybridizationFrequenciesGeneral PopulationHIVHIV InfectionsHistory of MedicineIn VitroIndividualInfectionIntervention TrialIntestinesInvestigationLabelLocationMeasurementMeasuresMemoryMethodsModelingMonitorNeurocognitiveNucleic AcidsPatientsPatternPhasePhenotypePopulationProcessProductionRNARecoveryResolutionSamplingSensitivity and SpecificitySignal TransductionSpecificitySpecimenSubgroupTestingTimeTissuesViralVirusVirus LatencyVirus Replicationantiretroviral therapyassay developmentbaseclinically relevantcostdesignhigh throughput screeningin vitro Modelin vivokillingsmacrophagenovelnovel therapeuticspopulation basedpreventpublic health relevancereactivation from latencyresearch studyscreening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Antiretroviral therapy (ART) for HIV infection is one of the most important and rapid advances in the history of medicine. However, while effective at limiting virus replication and slowing the course of disease, ART cannot be stopped without rapid rebound of virus and progression of disease. In addition, while AIDS is prevented in patients on ART, significant non-AIDS events such as cardiovascular disease and neurocognitive decline occur more frequently and at an earlier age in HIV-infected subjects on ART than in the general population. Finally, the epidemic is too large and the barriers to roll-out
too high to effectively treat every infected individual to end the epidemic. It is therefore imperative that we understand the mechanisms of how HIV persists in the infected individual to design novel therapies to eradicate the virus or functionally cure the patient. The first step in tis understanding is the development of assays to measure the level of virus persistence. Several assays exist, but have serious limitations in terms of how much information is provided, how quickly they can be performed, how expensive they are, and how variable the measurement is. We propose here a novel method to detect HIV-infected cells at single cell resolution using flow cytometry. This method, once optimized, will provide more information, be performed more rapidly, cost less, and have less variability than other assays for the measurement of HIV reservoirs. We will optimize this assay and then apply it to understand the state of the HIV reservoir in various groups of HIV-infected subjects to evaluate whether some clinically different subjects may have different sizes, activities, or reactivation potentials of their HIV reservoirs ad also to develop a high-throughput screening assay for the evaluation of novel therapeutics to reactivate or kill the latent reservoir. This process will demonstrate the utility of this assay an highlight situations in which it can be applied as well as disseminate the assay for use by others to apply as they see fit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Timing of ART and homeostasis of the persistent HIV reservoir in the adult
-
批准号:8921906
-
项目类别:
-
资助金额:$76.55万
-
财政年份:2015
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Novel flow cytometry-based assay for HIV-infected cells
-
批准号:8774585
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2013
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Layering of the human immune system, viral infections, and childhood asthma
-
批准号:8534024
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2012
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Administrative Core
-
批准号:8376384
-
项目类别:
-
资助金额:$10.12万
-
财政年份:2012
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Layering of the human immune system, viral infections, and childhood asthma
-
批准号:8298764
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2012
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Mechanisms of effective adaptive immunity in HCV treatment
-
批准号:8376379
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2012
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Layering of the human immune system, viral infections, and childhood asthma
-
批准号:8689898
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2012
-
负责人:JOSEPH M MCCUNE
-
依托单位:
ROLE OF IMMUNE ACTIVATION IN SIV PATHOGENESIS
-
批准号:8357276
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2011
-
负责人:JOSEPH M MCCUNE
-
依托单位:
INTERRUPTION OF MATERNAL-FETAL TRANSMISSION OF HIV
-
批准号:8357331
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2011
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Human immune system layering and the neonatal response to vaccines
-
批准号:8091879
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2011
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Human immune system layering and the neonatal response to vaccines
-
批准号:8232099
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2011
-
负责人:JOSEPH M MCCUNE
-
依托单位:
INTERRUPTION OF MATERNAL-FETAL TRANSMISSION OF HIV
-
批准号:8172612
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
ROLE OF IMMUNE ACTIVATION IN SIV PATHOGENESIS
-
批准号:8172549
-
项目类别:
-
资助金额:$15.21万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Bay Area Hepatitis C Cooperative Research Center
-
批准号:8282820
-
项目类别:
-
资助金额:$71.73万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
The Impact of Tolerance in the Newborn on Lentiviral Infection
-
批准号:7986397
-
项目类别:
-
资助金额:$78.35万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Mechanisms of effective adaptive immunity in HCV treatment
-
批准号:7919829
-
项目类别:
-
资助金额:$12.67万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
Bay Area Hepatitis C Cooperative Research Center
-
批准号:7911259
-
项目类别:
-
资助金额:$74.57万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
The Impact of Tolerance in the Newborn on Lentiviral Infection
-
批准号:8917622
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
The Impact of Tolerance in the Newborn on Lentiviral Infection
-
批准号:8500161
-
项目类别:
-
资助金额:$68.33万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
The Impact of Tolerance in the Newborn on Lentiviral Infection
-
批准号:8103842
-
项目类别:
-
资助金额:$74.4万
-
财政年份:2010
-
负责人:JOSEPH M MCCUNE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: